The development of improved photosensitizers is a key aspect in the establishment of photodynamic therapy (PDT) as a reliable treatment modality. In this chapter, we discuss how molecular design can lead to photosensitizers with higher selectivity and better efficiency, with focus on the importance of specific intracellular targeting in determining the cell death mechanism and, consequently, the PDT outcome.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-0716-2099-1_18 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!